pCMV-sadCas9-VP64 Citations (3)
Originally described in: CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency.Matharu N, Rattanasopha S, Tamura S, Maliskova L, Wang Y, Bernard A, Hardin A, Eckalbar WL, Vaisse C, Ahituv N Science. 2018 Dec 13. pii: science.aau0629. doi: 10.1126/science.aau0629. PubMed Journal
Articles Citing pCMV-sadCas9-VP64
| Articles |
|---|
Implantation of engineered adipocytes suppresses tumor progression in cancer models.
Nguyen HP, An K, Ito Y, Kharbikar BN, Sheng R, Paredes B, Murray E, Pham K, Bruck M, Zhou X, Biellak C, Ushiki A, Nobuhara M, Fong SL, Bernards DA, Lynce F, Dillon DA, Magbanua MJM, Huppert LA, Hammerlindl H, Klein JA, Valdiviez L, Fiehn O, Esserman L, Desai TA, Yee SW, Rosenbluth JM, Ahituv N.
Nat Biotechnol. 2025 Feb 4:10.1038/s41587-024-02551-2. doi: 10.1038/s41587-024-02551-2.
PubMed
Associated Plasmids |
| HAX1 inhibits apoptosis and promotes maturation of neutrophils. Yue H, Shi G, Tang J, Li X, Bai L. Cell Commun Signal. 2025 Jul 21;23(1):349. doi: 10.1186/s12964-025-02353-2. PubMed |
| Novel Function for Endothelial Protease-Activated Receptors in Modulating Insulin Receptor Activity With Implications for Diabetes. Rajala R, Griffin CT. Arterioscler Thromb Vasc Biol. 2025 Sep;45(9):1648-1663. doi: 10.1161/ATVBAHA.125.323140. Epub 2025 Jul 31. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.